View on web

THE TOP NEWS IN MARIJUANA LAW REFORM

Volume 27   •   Issue 24   •   June 13, 2024

Ninety-seven percent of those surveyed said that their condition "was a little, much, or very much better since starting medical cannabis."

The new law removes cannabis from the federal Drugs and Drug Trafficking Act and recognizes the rights of adults to privately possess and grow personal use quantities of cannabis.

Study: Americans Far More Likely To Report Secondhand Harms From Alcohol Than From Cannabis  6/10/24

NORML Remembers David Boaz  6/7/24

The US Drug Enforcement Administration is accepting comments from the public on whether to reclassify cannabis through July 22.

FEDERAL: Tell the White House and Congress to Support Descheduling

FEDERAL: Tell the White House to Expand Marijuana Pardons and Clemency

FEDERAL: Stop Federal Housing Discrimination Against Lawful Cannabis Users

FEDERAL: Tell Your Senators to Support the SAFER Banking Act

FEDERAL: Tell Your Representatives to Support the CURE Act

FEDERAL: Support the Veterans Equal Access Act

The law seeks to facilitate and fund medical cannabis research, including "research related to the efficacy and potential health effects of various cannabis delivery methods."

Cannabis terpenes produced pain-relieving effects that were roughly equal to those of morphine.

WATCH: NORML's Deputy Director joins the Association of Cannabinoid Specialists' podcast to discusses the latest developments in medical cannabis policy

LEARN: Easing federal marijuana rules: There's still a long way to go

NORML OP-ED: Rescheduling cannabis could be a historic development

FEDERAL: Zero-tolerance drug testing rules are exacerbating supply chain disruptions